31-JUL-2025- Inter alia, approved:- 1. Recommended Final dividend of 50% i.e. 0.50 paisa per equity share on face value of Rs.1/- each for the financial year ended March 31, 2025, subject to approval of the shareholders in the forthcoming 40th Annual General Meeting of the Company (?40th AGM?); 2. Re-appointment of M/s. BDO India LLP, a Chartered Accountant having LLP registration no. AAB-7880 as Internal Auditor of the Company for the financial year 2025-26. 3. Appointment of M/s. AVS & Associates, Practicing Company Secretaries, Peer Reviewed Firm as Secretarial Auditors of the Company for the audit period of five consecutive years commencing from F.Y. 2025-26 till F.Y. 2029-2030, subject to approval of the shareholders of the Company at the ensuing 40th AGM 4. Sale/Disposal of Step-down Subsidiary by the Wholly Owned Subsidiary of the Company: Bliss GVS International Pte. Ltd., a wholly owned subsidiary of Bliss GVS Pharma Limited, has transferred its entire holding of 51% equity shares in Greenlife Bliss Healthcare Limited to Greenlife Pharmaceuticals Limited. Pursuant to this disposal, Greenlife Bliss Healthcare Limited has ceased to be a subsidiary of Bliss GVS International Pte. Ltd. and, accordingly, also ceases to be a step-down subsidiary of Bliss GVS Pharma Limited. 5. Subject to shareholders and other statutory and regulatory approvals, as applicable, Issuance and allotment of upto 8,50,000 Equity Shares for non-cash consideration as Sweat Equity Shares to Mr. Gagan Harsh Sharma, Managing Director of the Company in accordance with the provisions of Chapter IV of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. 6. Subject to shareholders and other statutory and regulatory approvals, as applicable, Issuance and allotment of upto 3,60,000 Equity Shares for non-cash consideration as Sweat Equity Shares to Mr. Vishal Vijay Rao, Vice-President of the Company in accordance with the provisions of Chapter IV of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. 7. 40th Annual General Meeting ("40th AGM or AGM") of the Company for the financial year ended March 31, 2025 has been scheduled to be held on Thursday, July 31, 2025 at 11:30 A.M. through Video Conferencing (?VC?)/Other Audio Visual Means (?OAVM?) facility pursuant to the Circular No.14 / 2020 dated April 8, 2020, Circular No. 17 / 2020 dated April 13, 2020 and Circular No. 20 / 2020 dated May 5, 2020 and all other related subsequent circulars issued in this regard and latest one being General Circular No. 09/2024 dated September 19, 2024, issued by the Ministry of Corporate Affairs ("MCA Circulars") which does not require physical presence of members at a common venue. The deemed venue for the 40th AGM shall be the registered office of the Company.
Note: